Similarly, apigenin downregulated PKM2 in colon cancer cells by inhibiting the Wnt/catenin pathway and reducing the synthesis of the splicing factor polypyrimidine tract-binding protein 1, resulting in decreased cell proliferation [37]. This evidence concerns the gene PKM and malignant colon neoplasm.